Similar articles

• [Inhibition of the immune reaction following skin allograft by antithymocyte serum therapy of the donors].

  Petrányi G, Szegedi G, Fekete B. Petrányi G, et al. Orv Hetil. 1971 Aug 1;112(31):1852-5. Orv Hetil. 1971. PMID: 4941976 Hungarian. No abstract available.
• The effect of repeated "therapeutic" courses of antilymphocytic globulin administration on skin allograft survival time in rats.

  Andeson NF, Dalton RG. Andeson NF, et al. Transplantation. 1971 Jul;12(1):54-6. doi: 10.1097/00007890-197107000-00009. Transplantation. 1971. PMID: 4103650 No abstract available.
• Suppression of rat renal allograft rejection by antibody against lymphocyte antigen receptors.

  McKearn TJ, Finnegan A, Neu MR, Fitch FW, Stuart FP Jr. McKearn TJ, et al. Surg Forum. 1974;25(0):263-5. Surg Forum. 1974. PMID: 4612772 No abstract available.
• Survey of the current status of the clinical uses of antilymphocyte serum.

  Monaco AP, Codish SD. Monaco AP, et al. Surg Gynecol Obstet. 1976 Mar;142(3):417-26. Surg Gynecol Obstet. 1976. PMID: 766248 Review.
• [Antilymphocytic sera and their use in experimental and clinical medicine].

  Gluzman FA. Gluzman FA. Klin Khir (1962). 1971 Sep;9:72-82. Klin Khir (1962). 1971. PMID: 4107024 Review. Russian. No abstract available.